Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Highlights Advanced Drug Manufacturing Approaches In Budget Plan

Executive Summary

FDA wants more companies to adopt continuous manufacturing, which could expand the US manufacturing base.

You may also be interested in...



New CDER Lab Will Help Push Advanced Manufacturing Adoption

US FDA plans to open a manufacturing research lab near its White Oak headquarters in 2021 to facilitate evaluation of novel manufacturing technology.

Acting FDA Commissioner Sharpless Offers A Familiar List Of Priorities

Many of Sharpless' priorities continue the work of his predecessor, but also are designed to make "immediate and significant impact."

US FDA Budget Boost Would Increase Domestic Drug Manufacturing By Better Regulating New Technologies

FDA’s fiscal year 2020 budget request calls for spending on figuring out how to regulate new drug manufacturing technologies under the rubric of increasing US domestic manufacturing.

Related Content

Topics

UsernamePublicRestriction

Register

PS122513

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel